CYP2E1 and NQO1 genotypes and bladder cancer risk in a Lebanese population.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  International Journal of Molecular Epidemiology and Genetics

• Publication date

  2013-11-28

• Fields of study

  Medicine

• Identifiers
  PMID 24319536PMCID PMC3852640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Urinary bladder cancer risk factors: a Lebanese case- control study.

  2013cited by this paper
• Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis

  2013cited by this paper
• Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis

  2013cited by this paper
• Functional PstI/RsaI Polymorphism in CYP2E1 Is Associated with the Development, Progression and Poor Outcome of Gastric Cancer

  2012cited by this paper
• Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2.

  2012cited by this paper
• N-Acetyltransferase 1 (NAT1) Genotype: A Risk Factor for Urinary Bladder Cancer in a Lebanese Population

  2012cited by this paper
• CYP2E1 RsaI/PstI polymorphism and liver cancer risk among east Asians: a HuGE review and meta-analysis.

  2012cited by this paper
• Polymorphic Enzymes, Urinary Bladder Cancer Risk, and Structural Change in the Local Industry

  2012cited by this paper
• CYP2E1*5B, CYP2E1*6, CYP2E1*7B, CYP2E1*2, and CYP2E1*3 allele frequencies in iranian populations.

  2012cited by this paper
• Global cancer statistics

  2011cited by this paper
• Genetic Polymorphism of the Glutathione S-Transferase M1 and T1 Genes in Three Distinct Arab Populations

  2011cited by this paper
• GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.

  2011cited by this paper
• Association of Bladder Cancer Risk with an NAD(P)H:Quinone Oxidoreductase Polymorphism in an Ethnic Kashmiri Population

  2011cited by this paper
• Cytochrome P4502E1 (CYP2E1) Genetic Polymorphisms in a Lebanese Population: Frequency Distribution and Association with Morbid Diseases

  2010cited by this paper
• Cancer epidemiology in South-West Asia - past, present and future.

  2010cited by this paper
• Distribution of ADH1B, ALDH2, CYP2E1 *6, and CYP2E1 *7B genotypes in Turkish population.

  2010cited by this paper
• NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector.

  2010cited by this paper
• CANCER EPIDEMIOLOGY IN LEBANON

  2010cited by this paper
• Polymorphisms in GSTT1, GSTZ1, and CYP2E1, Disinfection By-products, and Risk of Bladder Cancer in Spain

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• The present and future burden of urinary bladder cancer in the world

  2009cited by this paper
• Expression of CYP2E1 in human nasopharynx and its metabolic effect in vitro

  2007cited by this paper
• NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Pro187Ser Polymorphism and the Risk of Lung, Bladder, and Colorectal Cancers: a Meta-analysis

  2006cited by this paper
• Genetic polymorphisms of CYP2E1 and GSTM1 in a Thai population.

  2006cited by this paper
• Cytochrome p450 2E1 polymorphisms and the risk of gastric cardia cancer.

  2005cited by this paper
• No Association Between SOD2 or NQO1 Genotypes and Risk of Bladder Cancer

  2005cited by this paper
• Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in North India.

  2005cited by this paper
• Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk.

  2004cited by this paper
• NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger.

  2004cited by this paper
• Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998.

  2004cited by this paper
• An association between NQO1 genetic polymorphism and risk of bladder cancer.

  2003cited by this paper
• CYP2E1 and NQO1 genotypes, smoking and bladder cancer.

  2003influential reference
• The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine

  2003cited by this paper
• Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.

  2003cited by this paper
• Evaluation of NQO1 gene expression and variant allele in human NSCLC tumors and matched normal lung tissue.

  2002cited by this paper
• NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: A HuGE review

  2002cited by this paper
• The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior.

  2001cited by this paper
• Changes in the expression of cytochrome P450 2E1 and the activity of carcinogen-metabolizing enzymes in Schistosoma haematobium-infected human bladder tissues.

  2001cited by this paper
• Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer.

  2001cited by this paper
• Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population.

  2001cited by this paper
• Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population.

  2001cited by this paper
• Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer

  2000cited by this paper
• Arylamine N-acetyltransferase 1 (NAT1) genotypes in a Lebanese population.

  2000cited by this paper
• Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues.

  2000cited by this paper
• Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer.

  1999cited by this paper
• Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1.

  1999cited by this paper
• Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe.

  1998cited by this paper
• Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations.

  1998cited by this paper
• Disruption of the DT Diaphorase (NQO1) Gene in Mice Leads to Increased Menadione Toxicity*

  1998cited by this paper
• Impact of CYP2E1 genotype in renal cell and urothelial cancer patients.

  1998cited by this paper
• Cancer in Lebanon: analysis of 10,220 cases from the American University of Beirut Medical Center.

  1998cited by this paper
• Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies.

  1997cited by this paper
• Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism.

  1997cited by this paper
• Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy.

  1997cited by this paper
• Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.

  1996cited by this paper
• Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients.

  1996cited by this paper
• Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk.

  1992cited by this paper
• NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.

  1992cited by this paper
• Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene.

  1991cited by this paper
• Association between Restriction Fragment Length Polymorphism of the Human Cytochrome P450IIE1 Gene and Susceptibility to Lung Cancer

  1991cited by this paper

• Polymorphisms in drug-metabolizing genes and urinary bladder cancer susceptibility and prognosis: Possible impacts and future management.

  2024cites this paper
• Pharmacogenomics in Lebanon: current status, challenges and opportunities

  2024cites this paper
• Genetic Polymorphisms Involved in Bladder Cancer: A Global Review

  2023cites this paper
• Genetic susceptibility of bladder cancer in the Lebanese population

  2022cites this paper
• AhRR methylation contributes to disease progression in urothelial bladder cancer

  2022cites this paper
• STUYDING ON GENOTYPE AND ALLELE FREQUENCY OF CYP2E1 *5B AND CYP2E1 *7B POLYMORPHISM AT A VIETNAMESE GROUP LIVING IN THE NOTHERN PROVINCES

  2022cites this paper
• Polymorphisms in NQO1 and MPO genes and risk for bladder cancer in Tunisian population

  2021cites this paper
• Sexual Dimorphism in Drug Metabolism and Pharmacokinetics.

  2020cites this paper
• Genotype-Environment Interaction Analysis of NQO1, CYP2E1, and NAT2 Polymorphisms and the Risk of Childhood Acute Lymphoblastic Leukemia: A Report From the Mexican Interinstitutional Group for the Identification of the Causes of Childhood Leukemia

  2020cites this paper
• The Influence of Genetic Variability on the Risk of Developing Malignant Mesothelioma

  2018cites this paper
• 2,4-Dimethylaniline generates phosphorylated histone H2AX in human urothelial and hepatic cells through reactive oxygen species produced by cytochrome P450 2E1

  2018cites this paper
• A systematic review and meta-analysis

  2018cites this paper
• Distribution and Role of N-acetyltransferase 2 Genetic Polymorphisms in Bladder Cancer Risk in a Lebanese Population

  2017cites this paper
• A dual inhibition: microRNA-552 suppresses both transcription and translation of cytochrome P450 2E1.

  2016cites this paper
• Bladder Cancer and Genetic Polymorphisms: A Review

  2015cites this paper
• Cytochrome P450 2E1 RsaI/PstI polymorphism is associated with urologic cancer risk: evidence from a meta-analysis.

  2015cites this paper
• The Association Between NQO1 Pro187Ser Polymorphism and Urinary System Cancer Susceptibility: A Meta-Analysis of 22 Studies

  2015influential citation
• Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers.

  2015influential citation
• The Association between NQO1 Pro187Ser Polymorphism and Bladder Cancer Susceptibility: A Meta-Analysis of 15 Studies

  2015cites this paper
• Cytochrome P 450 2 E 1 RsaI / PstI polymorphism is associated with urologic cancer risk : evidence from a meta-analysis

  2015influential citation
• Functional RsaI/PstI polymorphism in cytochrome P450 2E1 contributes to bladder cancer susceptibility: evidence from a meta-analysis.

  2014influential citation
• Toxicogenetic Profile and Cancer Risk in Lebanese

  2014cites this paper
• PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.

  2014cites this paper